Purpose and Scope
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the use of psoralen–ultraviolet A (PUVA) photochemotherapy. The document aims to update and expand on the previous guidelines by (i) offering an appraisal of all relevant literature since 1990, focusing on any key developments; (ii) addressing important, practical clinical questions relating to the primary guideline objective; (iii) providing guideline recommendations and, where appropriate, with some health economic implications; and (iv) discussing potential developments and future directions.
The guideline is presented as a detailed review with highlighted recommendations for practical use in the clinic (see section 15.0), in addition to the production of a patient information leaflet [available on the British Association of Dermatologists' (BAD) website, http://www.bad.org.uk].
The British Journal of Dermatology. 2016;174(1):24-55. © 2016 Blackwell Publishing
Comments